The COVID-19-related shutdown of a GE Healthcare plant in Shanghai has interrupted manufacture of iodinated contrast media used in many imaging exams. GE Healthcare’s and contrast media were added to the FDA drug shortage list on May 9. This shortage is forcing the delay of many non-emergency exams.
The 黑料网® offers the following resources to help practices continue to provide necessary care during this trying time. These resources are not intended to be — nor offered as — comprehensive medical guidelines. The 黑料网 will update this page as reliable information becomes available.